MedPath

Polycystic ovarian syndrome & Chronic Periodontitis

Not Applicable
Conditions
Health Condition 1: R888- Abnormal findings in other body fluids and substancesHealth Condition 2: E282- Polycystic ovarian syndrome
Registration Number
CTRI/2019/09/021214
Lead Sponsor
SERB DST
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women between 18 and 30 years of age.

2. PCOS diagnosis will be based on the criteria by Rotterdam2 with the presence of at least two of the following: polycystic ovaries, oligomenorrhea and/or anovulation, hyperandrogenism (clinical and/or biochemical)

3. Diagnosis of generalized moderate-to-severe chronic periodontitis will be based on presence of at least 20 teeth in the oral cavity, with at least 30% of the areas undergoing clinical attachment loss of at least 3 mm and a probing depth of >=5 mm and radiographic evidence of bone loss3.

4. The systemically healthy group will be based on; history of regular menstrual cycles, no clinical or biochemical sign of hyperandrogenism, matching with the PCOS group in body mass index (BMI) and exclusion of PCOS by ultrasound examination.

5. Willingness to sign consent for study including participation with collection of blood specimens

6. Willingness to discontinue OCP for duration of study period up to 18 weeks

Exclusion Criteria

Pregnancy

2. History of smoking or any drug usage, including oral contraceptives, systemic antibiotics (during the previous 6 months) or continuous use of NSAIDs

3. History of any dental treatment in the previous six months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to obtain an association between PCOS and chronic periodontitis <br/ ><br>To assess and compare serum and salivary bone marker levels in PCOS subjects with or without periodontitis before and after non surgical periodontal therapy <br/ ><br>To assess and compare bone density levels in PCOS subjects with or without periodontitis before and after non surgical periodontal therapyTimepoint: 0-18 Months
Secondary Outcome Measures
NameTimeMethod
serum testorone levels among PCOD females <br/ ><br>effect of non surgical periodontal therapy on pros symptoms <br/ ><br>bone marker levels in saliva and serumTimepoint: baseline to six months
© Copyright 2025. All Rights Reserved by MedPath